BRCA1 and HRR Variants Linked to Improved Survival in Brazilian Triple-Negative Breast Cancer
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
Preclinical and clinical investigations reveal that the transcription factor TFAP2A enhances radiotherapy resistance in non-small cell lung cancer by directly ...
Researchers have identified a prehistoric BRCA1 founder variant in Rwandan breast cancer cases that originated thousands of years ago.
Healthy women carrying pathogenic BRCA1 or BRCA2 variants have significantly fewer hypomethylated, presumably active ribosomal DNA copies in their blood ...
A retrospective single-center study of 148 patients found that two-thirds of women with germline BRCA-mutated breast cancer underwent risk-reducing salpingo-oophorectomy, ...
A study of 77 patients found matrix-producing metaplastic carcinoma of the breast is marked by frequent germline HRD gene variants, ...
New research shows that removing the chromatin remodeler ALC1 sensitizes a broad range of ovarian cancer models to PARP inhibitors ...
A retrospective Japanese cohort study associated expanded insurance coverage for BRCA testing with a median testing interval of 54 days ...
A cross-sectional study found that 36.16% of at-risk relatives underwent family-specific genetic testing, with uptake independently associated with education, family ...
A study of 58 patients found that ovarian cancer ascites-derived cell blocks supported immunohistochemical diagnosis and detected homologous recombination repair ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine